Immunitybio Inc
NASDAQ:IBRX

Watchlist Manager
Immunitybio Inc Logo
Immunitybio Inc
NASDAQ:IBRX
Watchlist
Price: 2.85 USD 3.26% Market Closed
Market Cap: 2.7B USD

Intrinsic Value

The intrinsic value of one IBRX stock under the Base Case scenario is 21.98 USD. Compared to the current market price of 2.85 USD, Immunitybio Inc is Undervalued by 87%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IBRX Intrinsic Value
21.98 USD
Undervaluation 87%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Immunitybio Inc

What is Valuation History?
Compare IBRX to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about IBRX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Immunitybio Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Immunitybio Inc

Current Assets 208.1m
Cash & Short-Term Investments 153.7m
Receivables 22.3m
Other Current Assets 32.1m
Non-Current Assets 193.9m
PP&E 167.7m
Intangibles 15m
Other Non-Current Assets 11.2m
Efficiency

Free Cash Flow Analysis
Immunitybio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Immunitybio Inc

Revenue
56.6m USD
Cost of Revenue
-6.3m USD
Gross Profit
50.3m USD
Operating Expenses
-335.7m USD
Operating Income
-285.4m USD
Other Expenses
-81.7m USD
Net Income
-367.1m USD
Fundamental Scores

IBRX Profitability Score
Profitability Due Diligence

Immunitybio Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROE
ROIC is Increasing
Exceptional Gross Margin
44/100
Profitability
Score

Immunitybio Inc's profitability score is 44/100. The higher the profitability score, the more profitable the company is.

IBRX Solvency Score
Solvency Due Diligence

Immunitybio Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Positive Net Debt
Long-Term Solvency
34/100
Solvency
Score

Immunitybio Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IBRX Price Targets Summary
Immunitybio Inc

Wall Street analysts forecast IBRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IBRX is 10.4 USD with a low forecast of 5.05 USD and a high forecast of 25.2 USD.

Lowest
Price Target
5.05 USD
77% Upside
Average
Price Target
10.4 USD
265% Upside
Highest
Price Target
25.2 USD
784% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Immunitybio Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for IBRX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

IBRX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one IBRX stock?

The intrinsic value of one IBRX stock under the Base Case scenario is 21.98 USD.

Is IBRX stock undervalued or overvalued?

Compared to the current market price of 2.85 USD, Immunitybio Inc is Undervalued by 87%.

Back to Top